the hull & east yorkshire medical research centre
the hull & east yorkshire medical research centre Company Information
Company Number
04017833
Next Accounts
Jun 2025
Shareholders
-
Group Structure
View All
Industry
General medical practice activities
Registered Address
the daisy building, castle hill hospital, cottingham, east yorkshire, HU16 5JQ
Website
www.daisyappeal.orgthe hull & east yorkshire medical research centre Estimated Valuation
Pomanda estimates the enterprise value of THE HULL & EAST YORKSHIRE MEDICAL RESEARCH CENTRE at £563.7k based on a Turnover of £934.4k and 0.6x industry multiple (adjusted for size and gross margin).
the hull & east yorkshire medical research centre Estimated Valuation
Pomanda estimates the enterprise value of THE HULL & EAST YORKSHIRE MEDICAL RESEARCH CENTRE at £3.3m based on an EBITDA of £724k and a 4.61x industry multiple (adjusted for size and gross margin).
the hull & east yorkshire medical research centre Estimated Valuation
Pomanda estimates the enterprise value of THE HULL & EAST YORKSHIRE MEDICAL RESEARCH CENTRE at £38m based on Net Assets of £13.8m and 2.75x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Hull & East Yorkshire Medical Research Centre Overview
The Hull & East Yorkshire Medical Research Centre is a live company located in cottingham, HU16 5JQ with a Companies House number of 04017833. It operates in the general medical practice activities sector, SIC Code 86210. Founded in June 2000, it's largest shareholder is unknown. The Hull & East Yorkshire Medical Research Centre is a mature, small sized company, Pomanda has estimated its turnover at £934.4k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Hull & East Yorkshire Medical Research Centre Health Check
Pomanda's financial health check has awarded The Hull & East Yorkshire Medical Research Centre a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
3 Weak
Size
annual sales of £934.4k, make it smaller than the average company (£1.6m)
£934.4k - The Hull & East Yorkshire Medical Research Centre
£1.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -9%, show it is growing at a slower rate (6.4%)
-9% - The Hull & East Yorkshire Medical Research Centre
6.4% - Industry AVG
Production
with a gross margin of 41.7%, this company has a comparable cost of product (41.7%)
41.7% - The Hull & East Yorkshire Medical Research Centre
41.7% - Industry AVG
Profitability
an operating margin of 58% make it more profitable than the average company (4.7%)
58% - The Hull & East Yorkshire Medical Research Centre
4.7% - Industry AVG
Employees
with 1 employees, this is below the industry average (17)
1 - The Hull & East Yorkshire Medical Research Centre
17 - Industry AVG
Pay Structure
on an average salary of £28.9k, the company has an equivalent pay structure (£34.5k)
£28.9k - The Hull & East Yorkshire Medical Research Centre
£34.5k - Industry AVG
Efficiency
resulting in sales per employee of £934.4k, this is more efficient (£85.4k)
£934.4k - The Hull & East Yorkshire Medical Research Centre
£85.4k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - The Hull & East Yorkshire Medical Research Centre
- - Industry AVG
Creditor Days
its suppliers are paid after 150 days, this is slower than average (25 days)
150 days - The Hull & East Yorkshire Medical Research Centre
25 days - Industry AVG
Stock Days
it holds stock equivalent to 4 days, this is less than average (15 days)
4 days - The Hull & East Yorkshire Medical Research Centre
15 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 54 weeks, this is more cash available to meet short term requirements (42 weeks)
54 weeks - The Hull & East Yorkshire Medical Research Centre
42 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 25.7%, this is a lower level of debt than the average (53.7%)
25.7% - The Hull & East Yorkshire Medical Research Centre
53.7% - Industry AVG
THE HULL & EAST YORKSHIRE MEDICAL RESEARCH CENTRE financials
The Hull & East Yorkshire Medical Research Centre's latest turnover from September 2023 is £934.4 thousand and the company has net assets of £13.8 million. According to their latest financial statements, The Hull & East Yorkshire Medical Research Centre has 1 employee and maintains cash reserves of £1.2 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 934,382 | 586,846 | 1,319,857 | 1,258,976 | 1,949,565 | 493,005 | 1,910,795 | 2,002,356 | 463,298 | 379,418 | 233,973 | 1,031,549 | 410,363 | 237,942 |
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | 279,968 | 42,551 | 913,721 | 862,952 | 1,590,846 | 155,402 | 1,538,167 | 1,642,526 | -176,631 | -40,406 | -16,247 | 959,506 | -861 | 196,382 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 279,968 | 42,551 | 913,721 | 862,952 | 1,590,846 | 155,402 | 1,538,167 | 1,642,526 | -176,631 | -40,406 | -16,247 | 959,506 | -861 | 196,382 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 279,968 | 42,551 | 913,721 | 862,952 | 1,590,846 | 155,402 | 1,538,167 | 1,642,526 | -176,631 | -40,406 | -16,247 | 959,506 | -861 | 196,382 |
| Employee Costs | 28,877 | 25,852 | 24,132 | 25,202 | 26,286 | 6,575 | 0 | 0 | 9,656 | 10,484 | 9,735 | 9,804 | 9,894 | 12,798 |
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 9,140,221 | 8,514,053 | 5,645,666 | 4,700,288 | 3,198,853 | 2,205,118 | 1,802,278 | 1,579,179 | 7,371,411 | 6,073,601 | 3,890,737 | 4,178,993 | 4,467,247 | 4,753,313 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 7,980,961 | 6,991,574 | 6,519,592 | 7,193,274 | 5,780,042 | 5,780,042 | 5,780,042 | 5,780,042 | 0 | 1 | 1 | 1 | 1 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 17,121,182 | 15,505,627 | 12,165,258 | 11,893,562 | 8,978,895 | 7,985,160 | 7,582,320 | 7,359,221 | 7,371,411 | 6,073,602 | 3,890,738 | 4,178,994 | 4,467,248 | 4,753,313 |
| Stock & work in progress | 6,735 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44,920 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 331,990 | 367,034 | 347,459 | 115,496 | 117,235 | 105,435 | 107,278 | 286,684 | 91,622 | 1,887,956 | 1,061,822 | 736,310 | 232,310 | 31,879 |
| Cash | 1,160,302 | 1,420,116 | 1,905,516 | 2,446,718 | 3,208,650 | 1,130,390 | 1,525,031 | 821,731 | 461,754 | 252,310 | 1,576,538 | 1,869,570 | 1,360,370 | 1,454,116 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,499,027 | 1,787,150 | 2,252,975 | 2,562,214 | 3,325,885 | 1,235,825 | 1,632,309 | 1,153,335 | 553,376 | 2,140,266 | 2,638,360 | 2,605,880 | 1,592,680 | 1,485,995 |
| total assets | 18,620,209 | 17,292,777 | 14,418,233 | 14,455,776 | 12,304,780 | 9,220,985 | 9,214,629 | 8,512,556 | 7,924,787 | 8,213,868 | 6,529,098 | 6,784,874 | 6,059,928 | 6,239,308 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 220,000 | 201,667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 224,243 | 12,384 | 24,964 | 19,482 | 11,103 | 16,723 | 179,769 | 14,276 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25,000 | 50,000 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 657,689 | 631,938 | 490,641 | 501,711 | 55,528 | 36,475 | 29,444 | 86,550 | 210,400 | 218,610 | 217,104 | 168,377 | 114,683 | 4,948 |
| total current liabilities | 1,101,932 | 845,989 | 515,605 | 521,193 | 66,631 | 53,198 | 209,213 | 100,826 | 235,400 | 268,610 | 217,104 | 168,377 | 114,683 | 4,948 |
| loans | 1,778,333 | 1,998,333 | 0 | 0 | 0 | 0 | 0 | 950,000 | 1,875,000 | 1,950,000 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 1,800,000 | 1,800,000 | 1,800,000 | 2,083,088 | 2,672,171 | 1,200,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 100,228 | 78,094 | 46,800 | 35,706 | 26,373 | 19,028 | 12,059 | 6,540 | 1,723 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 3,678,561 | 3,876,427 | 1,846,800 | 2,118,794 | 2,698,544 | 1,219,028 | 12,059 | 956,540 | 1,876,723 | 1,950,000 | 0 | 0 | 0 | 0 |
| total liabilities | 4,780,493 | 4,722,416 | 2,362,405 | 2,639,987 | 2,765,175 | 1,272,226 | 221,272 | 1,057,366 | 2,112,123 | 2,218,610 | 217,104 | 168,377 | 114,683 | 4,948 |
| net assets | 13,839,716 | 12,570,361 | 12,055,828 | 11,815,789 | 9,539,605 | 7,948,759 | 8,993,357 | 7,455,190 | 5,812,664 | 5,995,258 | 6,311,994 | 6,616,497 | 5,945,245 | 6,234,360 |
| total shareholders funds | 13,839,716 | 12,570,361 | 12,055,828 | 11,815,789 | 9,539,605 | 7,948,759 | 8,993,357 | 7,455,190 | 5,812,664 | 5,995,258 | 6,311,994 | 6,616,497 | 5,945,245 | 6,234,360 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 182,271 | 181,914 | 181,805 | 181,527 | 189,343 | 194,704 | 194,624 | 194,621 | 448,872 | 276,330 | 288,256 | 288,254 | 288,254 | 287,816 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 6,735 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -35,044 | 19,575 | 231,963 | -1,739 | 11,800 | -1,843 | -224,326 | 239,982 | -1,796,334 | 826,134 | 325,512 | 504,000 | 200,431 | 31,879 |
| Creditors | 211,859 | -12,580 | 5,482 | 8,379 | -5,620 | -163,046 | 165,493 | 14,276 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 25,751 | 141,297 | -11,070 | 446,183 | 19,053 | 7,031 | -57,106 | -123,850 | -8,210 | 1,506 | 48,727 | 53,694 | 109,735 | 4,948 |
| Deferred Taxes & Provisions | 22,134 | 31,294 | 11,094 | 9,333 | 7,345 | 6,969 | 5,519 | 4,817 | 1,723 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | 0 | 0 | 0 | 0 | 0 | -597,544 | -111,412 | -300,333 | ||||||
| Change in Investments | 989,387 | 471,982 | -673,682 | 1,413,232 | 0 | 0 | 0 | 5,780,042 | -1 | 0 | 0 | 0 | 1 | 0 |
| cash flow from investments | -989,387 | -471,982 | 673,682 | -1,413,232 | 0 | -597,544 | -111,412 | -6,080,375 | ||||||
| Financing Activities | ||||||||||||||
| Bank loans | 18,333 | 201,667 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25,000 | -25,000 | 50,000 | 0 | 0 | 0 | 0 |
| Long term loans | -220,000 | 1,998,333 | 0 | 0 | 0 | 0 | -950,000 | -925,000 | -75,000 | 1,950,000 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | -283,088 | -589,083 | 1,472,171 | 1,200,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| cash flow from financing | 787,720 | 2,671,982 | -956,770 | 824,149 | 1,472,171 | 0 | -950,000 | -950,000 | -105,963 | 1,723,670 | -288,254 | -288,254 | 6,037,978 | |
| cash and cash equivalents | ||||||||||||||
| cash | -259,814 | -485,400 | -541,202 | -761,932 | 2,078,260 | -394,641 | 703,300 | 359,977 | 209,444 | -1,324,228 | -293,032 | 509,200 | -93,746 | 1,454,116 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -259,814 | -485,400 | -541,202 | -761,932 | 2,078,260 | -394,641 | 703,300 | 359,977 | 209,444 | -1,324,228 | -293,032 | 509,200 | -93,746 | 1,454,116 |
the hull & east yorkshire medical research centre Credit Report and Business Information
The Hull & East Yorkshire Medical Research Centre Competitor Analysis
Perform a competitor analysis for the hull & east yorkshire medical research centre by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in HU16 area or any other competitors across 12 key performance metrics.
the hull & east yorkshire medical research centre Ownership
THE HULL & EAST YORKSHIRE MEDICAL RESEARCH CENTRE group structure
The Hull & East Yorkshire Medical Research Centre has 1 subsidiary company.
Ultimate parent company
THE HULL & EAST YORKSHIRE MEDICAL RESEARCH CENTRE
04017833
1 subsidiary
the hull & east yorkshire medical research centre directors
The Hull & East Yorkshire Medical Research Centre currently has 9 directors. The longest serving directors include Professor Nicholas Stafford (Jun 2000) and Professor Michael Lind (Jun 2000).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Professor Nicholas Stafford | 70 years | Jun 2000 | - | Director | |
| Professor Michael Lind | United Kingdom | 67 years | Jun 2000 | - | Director |
| Mr Trevor Boanas | 78 years | Sep 2003 | - | Director | |
| Dr Christopher Rowland-Hill | England | 67 years | Jan 2009 | - | Director |
| Mr Sydney Howey | 87 years | Mar 2010 | - | Director | |
| Mr Peter Dyer | 77 years | Mar 2010 | - | Director | |
| Miss Karen Guest | England | 60 years | Oct 2013 | - | Director |
| Mrs Victoria Heuck | United Kingdom | 66 years | Mar 2016 | - | Director |
| Mr David Heuck | England | 63 years | Mar 2020 | - | Director |
P&L
September 2023turnover
934.4k
+59%
operating profit
541.7k
0%
gross margin
41.7%
-4.32%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
13.8m
+0.1%
total assets
18.6m
+0.08%
cash
1.2m
-0.18%
net assets
Total assets minus all liabilities
the hull & east yorkshire medical research centre company details
company number
04017833
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86210 - General medical practice activities
incorporation date
June 2000
age
25
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
September 2023
previous names
hull centre for cancer & cardiac research (January 2001)
accountant
-
auditor
SMAILES GOLDIE
address
the daisy building, castle hill hospital, cottingham, east yorkshire, HU16 5JQ
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
GORDONS LLP GOSSCHALKS
the hull & east yorkshire medical research centre Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to the hull & east yorkshire medical research centre.
the hull & east yorkshire medical research centre Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for THE HULL & EAST YORKSHIRE MEDICAL RESEARCH CENTRE. This can take several minutes, an email will notify you when this has completed.
the hull & east yorkshire medical research centre Companies House Filings - See Documents
| date | description | view/download |
|---|
